News

Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, ...
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...